scholarly journals Machine Learning the Phenomenology of COVID-19 From Early Infection Dynamics

Author(s):  
Malik Magdon-Ismail

AbstractWe present a robust data-driven machine learning analysis of the COVID-19 pandemic from its early infection dynamics, specifically infection counts over time. The goal is to extract actionable public health insights. These insights include the infectious force, the rate of a mild infection becoming serious, estimates for asymtomatic infections and predictions of new infections over time. We focus on USA data starting from the first confirmed infection on January 20 2020. Our methods reveal significant asymptomatic (hidden) infection, a lag of about 10 days, and we quantitatively confirm that the infectious force is strong with about a 0.14% transition from mild to serious infection. Our methods are efficient, robust and general, being agnostic to the specific virus and applicable to different populations or cohorts.

2021 ◽  
Vol 5 (1) ◽  
pp. 5
Author(s):  
Ninghan Chen ◽  
Zhiqiang Zhong ◽  
Jun Pang

The outbreak of the COVID-19 led to a burst of information in major online social networks (OSNs). Facing this constantly changing situation, OSNs have become an essential platform for people expressing opinions and seeking up-to-the-minute information. Thus, discussions on OSNs may become a reflection of reality. This paper aims to figure out how Twitter users in the Greater Region (GR) and related countries react differently over time through conducting a data-driven exploratory study of COVID-19 information using machine learning and representation learning methods. We find that tweet volume and COVID-19 cases in GR and related countries are correlated, but this correlation only exists in a particular period of the pandemic. Moreover, we plot the changing of topics in each country and region from 22 January 2020 to 5 June 2020, figuring out the main differences between GR and related countries.


2021 ◽  
Author(s):  
Carlos Eduardo Beluzo ◽  
Luciana Correia Alves ◽  
Natália Martins Arruda ◽  
Cátia Sepetauskas ◽  
Everton Silva ◽  
...  

ABSTRACTReduction in child mortality is one of the United Nations Sustainable Development Goals for 2030. In Brazil, despite recent reduction in child mortality in the last decades, the neonatal mortality is a persistent problem and it is associated with the quality of prenatal, childbirth care and social-environmental factors. In a proper health system, the effect of some of these factors could be minimized by the appropriate number of newborn intensive care units, number of health care units, number of neonatal incubators and even by the correct level of instruction of mothers, which can lead to a proper care along the prenatal period. With the intent of providing knowledge resources for planning public health policies focused on neonatal mortality reduction, we propose a new data-driven machine leaning method for Neonatal Mortality Rate forecasting called NeMoR, which predicts neonatal mortality rates for 4 months ahead, using NeoDeathForecast, a monthly base time series dataset composed by these factors and by neonatal mortality rates history (2006-2016), having 57,816 samples, for all 438 Brazilian administrative health regions. In order to build the model, Extra-Tree, XGBoost Regressor, Gradient Boosting Regressor and Lasso machine learning regression models were evaluated and a hyperparameters search was also performed as a fine tune step. The method has been validated using São Paulo city data, mainly because of data quality. On the better configuration the method predicted the neonatal mortality rates with a Mean Square Error lower than 0.18. Besides that, the forecast results may be useful as it provides a way for policy makers to anticipate trends on neonatal mortality rates curves, an important resource for planning public health policies.Graphical AbstractHighlightsProposition of a new data-driven approach for neonatal mortality rate forecast, which provides a way for policy-makers to anticipate trends on neonatal mortality rates curves, making a better planning of health policies focused on NMR reduction possible;a method for NMR forecasting with a MSE lower than 0.18;an extensive evaluation of different Machine Learning (ML) regression models, as well as hyperparameters search, which accounts for the last stage in NeMoR;a new time series database for NMR prediction problems;a new features projection space for NMR forecasting problems, which considerably reduces errors in NRM prediction.


2020 ◽  
Vol 28 (1) ◽  
pp. 192-201
Author(s):  
G. Ntaios ◽  
S. F. Weng ◽  
K. Perlepe ◽  
R. Akyea ◽  
L. Condon ◽  
...  

2021 ◽  
Vol 153 ◽  
pp. 111588
Author(s):  
Michel Alexandre ◽  
Thiago Christiano Silva ◽  
Colm Connaughton ◽  
Francisco A. Rodrigues

2020 ◽  
Author(s):  
Colin M. Van Oort ◽  
Jonathon B. Ferrell ◽  
Jacob M. Remington ◽  
Safwan Wshah ◽  
Jianing Li

AbstractAntibiotic resistance is a critical public health problem. Each year ~2.8 million resistant infections lead to more than 35,000 deaths in the U.S. alone. Anti-microbial peptides (AMPs) show promise in treating resistant infections. But, applications of known AMPs have encountered issues in development, production, and shelf-life. To drive the development of AMPbased treatments it is necessary to create design approaches with higher precision and selectivity towards resistant targets.In this paper we present AMPGAN v2, a generative adversarial network (GAN) based approach for rational AMP design. Like AMP-GAN,1 AMPGAN v2 combines data driven priors and controlled generation. These elements allow for the generation of AMP candidates tailored for specific applications. AMPGAN v2 is able to generate AMP candidates that are novel and diverse, making it an efficient AMP design tool.


2020 ◽  
Author(s):  
Adriano Veloso ◽  
Nivio Ziviani

Models have gained the spotlight in many discussions surrounding COVID-19. The urgency for timely decisions resulted in a multitude of models as informed policy actions must be made even when so many uncertainties about the pandemic still remain. In this paper, we use machine learning algorithms to build intuitive country-level COVID-19 motion models described by death toll velocity and acceleration. Model explainability techniques provide insightful data-driven narratives about COVID-19 death toll motion models $-$ while velocity is explained by factors that are increasing/reducing death toll pace now, acceleration anticipates the effects of public health measures on slowing the death toll pace. This allows policymakers and epidemiologists to understand factors driving the outbreak and to evaluate the impacts of different public health measures. Finally, our models also predict counterfactuals in order to face the challenge of estimating what is likely to happen as a result of an action.


Author(s):  
Kunal Parikh ◽  
Tanvi Makadia ◽  
Harshil Patel

Dengue is unquestionably one of the biggest health concerns in India and for many other developing countries. Unfortunately, many people have lost their lives because of it. Every year, approximately 390 million dengue infections occur around the world among which 500,000 people are seriously infected and 25,000 people have died annually. Many factors could cause dengue such as temperature, humidity, precipitation, inadequate public health, and many others. In this paper, we are proposing a method to perform predictive analytics on dengue’s dataset using KNN: a machine-learning algorithm. This analysis would help in the prediction of future cases and we could save the lives of many.


Author(s):  
Barbara Tempalski ◽  
Leslie D. Williams ◽  
Brooke S. West ◽  
Hannah L. F. Cooper ◽  
Stephanie Beane ◽  
...  

Abstract Background Adequate access to effective treatment and medication assisted therapies for opioid dependence has led to improved antiretroviral therapy adherence and decreases in morbidity among people who inject drugs (PWID), and can also address a broad range of social and public health problems. However, even with the success of syringe service programs and opioid substitution programs in European countries (and others) the US remains historically low in terms of coverage and access with regard to these programs. This manuscript investigates predictors of historical change in drug treatment coverage for PWID in 90 US metropolitan statistical areas (MSAs) during 1993–2007, a period in which, overall coverage did not change. Methods Drug treatment coverage was measured as the number of PWID in drug treatment, as calculated by treatment entry and census data, divided by numbers of PWID in each MSA. Variables suggested by the Theory of Community Action (i.e., need, resource availability, institutional opposition, organized support, and service symbiosis) were analyzed using mixed-effects multivariate models within dependent variables lagged in time to study predictors of later change in coverage. Results Mean coverage was low in 1993 (6.7%; SD 3.7), and did not increase by 2007 (6.4%; SD 4.5). Multivariate results indicate that increases in baseline unemployment rate (β = 0.312; pseudo-p < 0.0002) predict significantly higher treatment coverage; baseline poverty rate (β = − 0.486; pseudo-p < 0.0001), and baseline size of public health and social work workforce (β = 0.425; pseudo-p < 0.0001) were predictors of later mean coverage levels, and baseline HIV prevalence among PWID predicted variation in treatment coverage trajectories over time (baseline HIV * Time: β = 0.039; pseudo-p < 0.001). Finally, increases in black/white poverty disparity from baseline predicted significantly higher treatment coverage in MSAs (β = 1.269; pseudo-p < 0.0001). Conclusions While harm reduction programs have historically been contested and difficult to implement in many US communities, and despite efforts to increase treatment coverage for PWID, coverage has not increased. Contrary to our hypothesis, epidemiologic need, seems not to be associated with change in treatment coverage over time. Resource availability and institutional opposition are important predictors of change over time in coverage. These findings suggest that new ways have to be found to increase drug treatment coverage in spite of economic changes and belt-tightening policy changes that will make this difficult.


Sign in / Sign up

Export Citation Format

Share Document